Chris Dallas Feeney, PhD
About Chris Dallas Feeney, PhD
Chris Dallas Feeney, PhD, is an adjunct professor of political science at George Washington University and Saint Joseph's University, with a background in business administration and political science. He also serves as the senior vice president at AmeriHealth Caritas and has held various roles in academia and the pharmaceutical industry.
Work at The George Washington University
Chris Dallas Feeney, PhD, has served as an Adjunct Professor of Political Science at The George Washington University since 2013. In this role, he engages with students in the field of political science, contributing to their academic development and understanding of political systems. His tenure at the university spans over 11 years, during which he has utilized his extensive knowledge and experience in the subject matter to enhance the learning environment.
Education and Expertise
Chris Dallas Feeney holds a Doctor of Philosophy in Political Science from The George Washington University, which he completed from 2006 to 2013. Prior to this, he earned a Master of Arts from Georgetown University between 2003 and 2006. He also obtained a Bachelor of Science in Business Administration from Penn State University, studying from 1973 to 1977. This diverse educational background equips him with a comprehensive understanding of both political and business disciplines.
Current Professional Roles
In addition to his academic positions, Chris Dallas Feeney serves as the Senior Vice President at AmeriHealth Caritas, a role he has held since 2019. His responsibilities in this position involve overseeing various strategic initiatives within the organization. He also works as an Adjunct Professor at Saint Joseph's University in Philadelphia, Pennsylvania, where he has been teaching since 2017, further contributing to his commitment to education and mentorship.
Previous Experience
Before his current roles, Chris Dallas Feeney worked at Novartis as the Head of Market Access Strategy and Operations from 2018 to 2019. In this capacity, he was responsible for developing and implementing strategies to improve market access for the company's products. His experience in the pharmaceutical industry adds to his expertise in political science and business administration.